Prime Medicine, Inc. (PRME)
NASDAQ·Healthcare·Biotechnology
$4.32
-6.67%
Mkt Cap $807.13M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (8 analysts)
$7.50
Range $6.00 – $9.00
Implied Upside
+73.6%
Consensus $7.50 vs current $4.32
NASDAQ·Healthcare·Biotechnology
$4.32
-6.67%
Mkt Cap $807.13M
Buy
5
Hold
0
Sell
0
Price Target (8 analysts)
$7.50
Range $6.00 – $9.00
+73.6%
Consensus $7.50 vs current $4.32